Pulmatrix, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Pulmatrix, Inc. on January 13, 2017, reporting an event that occurred on January 11, 2017. The company is incorporated in Delaware and maintains its principal executive offices in Lexington, MA.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes
On January 11, 2017, Pulmatrix, Inc. received notification from the Nasdaq Stock Market that it failed to meet the continued listing requirement for the Nasdaq Global Select Market under Listing Rule 5450(b)(1)(C). Specifically, the company's Market Value of Publicly Held Shares (MVPHS) fell below the required minimum of $5,000,000.
Outlook, Risks, and Contingencies
- Listing Status: The notification does not immediately impact the company's listing on the Nasdaq Global Select Market.
- Compliance Period: The company has been granted 180 calendar days, until July 10, 2017, to regain compliance.
- Remediation Requirement: To restore compliance, the company's MVPHS must close at $5,000,000 or more for a minimum of 10 consecutive business days within the compliance period.
Key Facts for Investor Verification
- Verify the current Market Value of Publicly Held Shares (MVPHS) to assess the gap to the $5,000,000 threshold.
- Monitor the company's stock price and share count over the next 10 consecutive business days to track progress toward compliance.
- Review subsequent filings for any announcements regarding capital raises or strategic actions intended to increase MVPHS before the July 10, 2017 deadline.